Apogee Therapeutics, Inc. (APGE)
$135.02+$0.06 (+0.04%) Today
Carl Dambkowski - Officer
Michael Thomas Henderson - OfficerCarl Dambkowski - OfficerCarl Dambkowski - OfficerMichael Thomas Henderson - OfficerMichael Thomas Henderson - OfficerMichael Thomas Henderson - OfficerMichael Thomas Henderson - OfficerApogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
https://www.apogeetherapeutics.comSEC filings for APGE on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 12 | 162,900 | $20.34M |
| Grant or award | 6 | 45,942 | |
| Option exercise | 10 | 109,166 | |
| Bona-fide gift | 3 | 98,046 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
57 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC - Director | Option exercise | Common Stock | 31,838 | $17.00 | $541K | |
| Fairmount Funds Management LLC - Director | Option exercise | Common Stock | 10,370 | $43.85 | $455K | |
| Fairmount Funds Management LLC - Director | Option exercise | Stock Option (Right to Buy) | 31,838 | $0.00 | - | |
| Fairmount Funds Management LLC - Director | Option exercise | Stock Option (Right to Buy) | 10,370 | $0.00 | - | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 4,125 | $22.86 | $94K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,500 | $134.17 | $738K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 4,125 | $0.00 | - | |
 Jane Henderson - Officer | Gift | Common Stock | 15,000 | $0.00 | - | |
| Carl Dambkowski - Officer | Gift | Common Stock | 8,000 | $0.00 | - | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 20,000 | $133.63 | $2.67M | |
| Michael Thomas Henderson - Officer | Gift | Common Stock | 75,046 | $0.00 | - | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 4,125 | $22.86 | $94K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,500 | $132.74 | $730K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 4,125 | $0.00 | - | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 26,400 | $132.60 | $3.50M | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 80,000 | $132.54 | $10.60M | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 2,305 | $86.27 | $199K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 614 | $86.89 | $53K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 6,770 | $82.21 | $557K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 7,654 | $82.78 | $634K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,080 | $84.18 | $91K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,577 | $85.19 | $134K | |
| Fairmount Funds Management LLC - Director | Grant or award | Stock Option (Right to Buy) | 7,657 | $0.00 | - | |
| Nimish P. Shah - Director | Grant or award | Stock Option (Right to Buy) | 7,657 | $0.00 | - | |
| Mark C. McKenna - Director | Grant or award | Stock Option (Right to Buy) | 7,657 | $0.00 | - | |
| William A. Jones Jr. - Director | Grant or award | Stock Option (Right to Buy) | 7,657 | $0.00 | - | |
| Jennifer A. Fox - Director | Grant or award | Stock Option (Right to Buy) | 7,657 | $0.00 | - | |
| Lisa Bollinger - Director | Grant or award | Stock Option (Right to Buy) | 7,657 | $0.00 | - | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 4,125 | $22.86 | $94K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,500 | $78.71 | $433K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 4,125 | $0.00 | - | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 18,659 | $82.05 | $1.53M | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,341 | $82.58 | $111K | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 4,125 | $22.86 | $94K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 3,700 | $83.92 | $311K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 1,800 | $84.60 | $152K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 4,125 | $0.00 | - | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 811 | $81.02 | $66K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 900 | $82.60 | $74K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 289 | $83.16 | $24K | |
| Michael Thomas Henderson - Officer | Option exercise | Common Stock | 3,000 | $22.86 | $69K | |
| Michael Thomas Henderson - Officer | Option exercise | Stock Option (Right to Buy) | 3,000 | $0.00 | - | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 2,000 | $90.00 | $180K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 17,800 | $82.48 | $1.47M | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 2,000 | $83.26 | $167K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 200 | $85.00 | $17K | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 4,125 | $22.86 | $94K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,698 | $84.31 | $227K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,702 | $85.33 | $231K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 100 | $85.89 | $9K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 4,125 | $0.00 | - | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 900 | $84.46 | $76K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 1,100 | $85.46 | $94K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 2,000 | $85.00 | $170K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 8,363 | $74.29 | $621K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 8,219 | $74.83 | $615K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 3,418 | $75.86 | $259K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 200 | $73.26 | $15K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 4,125 | $0.00 | - | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 4,125 | $22.86 | $94K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 3,225 | $70.33 | $227K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,075 | $71.98 | $149K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 300 | $68.27 | $20K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 300 | $69.43 | $21K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 994 | $70.45 | $70K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 406 | $71.66 | $29K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 11,494 | $62.96 | $724K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 7,551 | $63.73 | $481K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 955 | $64.99 | $62K | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 4,125 | $22.86 | $94K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,481 | $64.88 | $161K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 1,420 | $65.83 | $93K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 1,299 | $66.85 | $87K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 100 | $67.88 | $7K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 200 | $68.94 | $14K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 4,125 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Apogee Therapeutics, Inc. (APGE) had 16 insider filings in the last 90 days, with the most recent on 2026-08-11. The full record for APGE runs to 57 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of APGE were filed in the last 90 days. 3 purchases are on record for this company.
12 insider sales of APGE were filed in the last 90 days, totaling $20.34M.
This page tracks APGE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add APGE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
